Emergent BioSolutions Inc. (NYSE:EBS) Q4 2024 Earnings Call Transcript March 3, 2025
Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.05, expectations were $-0.35.
Operator: Good day, and thank you for standing by. Welcome to Emergent BioSolutions Inc. Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question and answer session. To ask a question during the...
